Summary and close - Reducing cardiovascular mortality in patients with type 2 diabetes: closing the gap between evidence and practice.
Congress Presentation
About the speaker
Professor Nikolaus Marx
5 more presentations in this session
Welcome and introduction - Reducing cardiovascular mortality in patients with type 2 diabetes: closing the gap between evidence and practice.
Speaker: Professor N. Marx (Aachen, DE)
Evidence-based approaches to reducing premature cardiovascular mortality in patients with type 2 diabetes and established cardiovascular disease.
Speaker: Professor D. McGuire (Dallas, US)
Applying evidence in practice: appropriate use of empagliflozin in patients with type 2 diabetes and established cardiovascular disease in the cardiology clinic.
Speaker: Doctor J. Udell (Toronto, CA) Professor N. Sattar (Glasgow, GB)
Advancing the standard of care in patients with type 2 diabetes and established cardiovascular disease: how can we improve patient outcomes? .
Speaker: Professor N. Marx (Aachen, DE) Professor D. McGuire (Dallas, US) Doctor J. Udell (Toronto, CA) Professor S. Verma (Toronto, CA) Professor N. Sattar (Glasgow, GB)
Exploring the effects of SGLT2 inhibition in ongoing trials.
Speaker: Professor S. Verma (Toronto, CA)
Access the full session
Reducing cardiovascular mortality in patients with type 2 diabetes: closing the gap between evidence and practice
About the event
ESC 365 is supported by
